BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shrink tumors before colon cancer surgery
Disease control Recruiting nowThis study is testing whether giving two targeted cancer drugs—encorafenib and cetuximab—before surgery can shrink tumors in patients with a specific genetic mutation (BRAF V600E) in their localized colon or upper rectal cancer. The goal is to see if this 'neoadjuvant' treatment …
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists track 400 patients to crack code of aggressive colon cancer
Knowledge-focused Recruiting nowThis study aims to gather real-world information about how patients with a specific, hard-to-treat form of metastatic colorectal cancer (with a BRAF gene mutation) are treated and how they fare over time. Researchers will collect medical records and blood/tissue samples from 400 …
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: NA • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:04 UTC